Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.
about
Topical brimonidine tartrate 0·33% gel effectively reduces the post-treatment erythema of daylight-activated photodynamic therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@en
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@nl
type
label
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@en
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@nl
prefLabel
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@en
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@nl
P2860
P356
P1476
Topical brimonidine tartrate 0 ...... ctivated photodynamic therapy.
@en
P2860
P304
P356
10.1111/BJD.14384
P407
P577
2016-01-03T00:00:00Z